Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge … – Sacramento Bee

Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge
Sacramento Bee
ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as

and more »

View full post on asthma – Google News

Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge … – PR Newswire (press release)

Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge
PR Newswire (press release)
ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as

and more »

View full post on asthma – Google News

FDA Approves Pharmaxis’ Asthma Test Kit Aridol – TopNews United Kingdom


TopNews Arab Emirates

FDA Approves Pharmaxis' Asthma Test Kit Aridol
TopNews United Kingdom
Pharmaxis' asthma test kit Aridol has been shown green signal by the US Food and Drug Administration for commercialization in US.
US approves Pharmaxis asthma testSydney Morning Herald
Pharmaxis (PXS) $2.40: Tim BorehamThe Australian
Pharmaxis gets the right news at the right timeTopNews Arab Emirates
irasia.com (press release)
all 11 news articles »

View full post on asthma – Google News